Business Wire

teamLab Planets TOKYO: Tickets purchased from overseas have increased by 136% compared to the same month in 2019 (before the COVID-19 pandemic), with one in three visitors coming from overseas

Share

teamLab Planets is a museum where visitors walk through water, and a garden where people become one with the flowers. The experiential museum has welcomed a cumulative total of over 3 million visitors since its opening in July 2018.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20221117005639/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

teamLab, Floating Flower Garden; Flowers and I are of the Same Root, the Garden and I are One © teamLab

[Several new areas introduced during the pandemic]

Despite the impact of the coronavirus pandemic in 2020, various new areas have opened at the museum as featured on notable media such as CNN during the pandemic, including two large-scale artworks in the Garden Area, and an adjoining vegan ramen restaurant originating from Kyoto.

[Increase in foreign visitors due to the lifting of the ban on individual travel to Japan and the expansion of new areas]

On October 11, 2022, the Japanese government significantly eased the COVID-19 border measures. The ban on individual travel to Japan has been lifted, visa exemptions have returned and the daily limit on the number of people entering Japan has been removed. In response, tourism to Japan has resumed properly for the first time in about two and a half years.

Around a month since the lifting of the ban on individual travel to Japan on October 11, tickets purchased by visitors from overseas increased by 136% compared to the same month in 2019 (before COVID-19), with one in three visitors coming from overseas. (*1)
More than half of the visitors from overseas purchased their tickets before visiting Japan, and a trend has been seen in which the museum is one of the purposes for people to visit Tokyo. (*2)
In the visitor questionnaire, there have been positive comments from visitors from overseas, such as "I've been wanting to go to the museum since the renewal."

(*1) According to ticket purchase data from the teamLab Planets official website: survey period - October 11 (Tue) to November 6 (Sun), 2022, and October 11 (Fri) to November 6 (Wed) 2019
(*2) According to ticket purchase data from the teamLab Planets official website: survey period - October 11 (Tue) and November 6 (Sun), 2022

[High praise from travel magazines]

In recent years the museum has been featured in notable publications such as Lonely Planet, a world-famous travel guidebook, which introduced it as one of “The 7 best museums in Tokyo that even Tokyoites line up for”, as well as in “The 26 Best Things to Do in Tokyo” by Condé Nast Traveler.

We look forward to welcoming visitors that are sightseeing in Tokyo to experience the museum, which has evolved through new artwork spaces.

The museum will continue to provide people from around the world an experience based on the concept of teamLab Planets, “Immerse your Body, and with Others, Become One with the World”.

Garden Area

The Garden Area was unveiled in July 2021 featuring two large-scale artworks, including a garden with over 13,000 live orchids and a surreal art space with ovoids scattered across a floor covered in real moss. These new art spaces can only be experienced here, and explore people’s relationship with nature and the world through digital technology. By incorporating natural light in space, the works reveal different aspects during the day and after sunset.

Floating Flower Garden; Flowers and I are of the Same Root, the Garden and I are One
Artwork: https://planets.teamlab.art/tokyo/ew/ffgarden_planets/

Moss Garden of Resonating Microcosms - Solidified Light Color, Sunrise and Sunset
Artwork: https://planets.teamlab.art/tokyo/ew/resonating_microcosms_mossgarden_planets/

Food and Art: Enjoy vegan ramen in an art space

Vegan Ramen UZU Tokyo, a vegan ramen restaurant originating from Kyoto, opened in October 2021 on the same premises as teamLab Planets. Diners can enjoy ramen in teamLab’s Reversible Rotation - Non-Objective Space artwork space, as well as the Table of Sky and Fire and One Stroke Bench outside of the restaurant. Vegan Ramen UZU Tokyo also has vegan ice cream and various teas that are only available in Tokyo. The restaurant can be visited without entry to teamLab Planets.

Vegan Ramen UZU Tokyo: https://vegan-uzu.com/pages/uzu-tokyo

Public art that can be experienced by all

Universe of Fire Particles Falling from the Sky is a work of public art that depicts flames, on display since April 2021. Flames, which are a phenomenon of light and heat generated by combustion, are expressed as a collection of lines drawn in relation to the flow of combusting gas. The work is displayed outdoors and can be viewed by anyone, regardless of whether or not they enter the museum.

Universe of Fire Particles Falling from the Sky
Artwork: https://planets.teamlab.art/tokyo/ew/universe_fireparticles_falling/

[ teamLab Planets TOKYO DMM ]

teamLab Planets is a museum where you walk through water, and a garden where you become one with the flowers. There are four massive exhibition spaces and two gardens.

By immersing your entire body with other people in these massive artworks, the boundary between the body and the artwork dissolves. The self, others, and the world become continuous, and we explore a new relationship without boundaries between ourselves and the world.

Enter barefoot, immerse your body with others in the artwork spaces, and become one with the world.

[Exhibition details]

teamLab Planets TOKYO DMM
Location: teamLab Planets TOKYO, 6-1-16 Toyosu, Koto-ku, Tokyo

[Opening hours]

(November - January)
Mon - Fri 10:00 - 20:00
Saturdays, Sundays, and holidays 9:00 - 21:00
* December 26 (Mon) - December 30 (Fri), January 2 (Mon) - January 6 (Fri) 9:00 - 21:00
* December 31 (Sat), January 1 (Sun) 9:00 - 20:00
* Last entry is 1 hour before closing

Closed:
December 8 (Thu), January 11 (Wed)

*Opening hours are subject to change. Please check the official website for the latest updates.

Official website: https://planets.teamlab.art/tokyo/jp/
teamLab Planets Highlight Video: https://youtu.be/oiQoe9Ow9o0

*teamLab Planets will be open in Toyosu, Tokyo until the end of 2023.

[Tickets]

Adult: 3,200 yen
Junior high and high school students: 2,000 JPY
Children (4 to 12 years old): 1,000 JPY
3 years old and under: Free
Disability discount: 1,600 JPY

teamLab Planets TOKYO DMM Ticket Store: https://teamlabplanets.dmm.com

[Measures to prevent the spread of COVID-19s]

Please check the link below for details on the infection prevention measures implemented at teamLab Planets:
https://teamlabplanets.dmm.com/covid-19

[Official HP/Social Media]

Official website: https://planets.teamlab.art/tokyo/
Instagram: https://www.instagram.com/teamlab.planets/
Facebook: https://www.facebook.com/TL.Planets/
Twitter: https://twitter.com/teamLabPlanets
#teamLabPlanets

[Food & Shop]

Vegan Ramen UZU Tokyo: https://vegan-uzu.com/pages/uzu-tokyo
teamLab Flower Shop & Art
*Please check the official website for opening hours
*Closed on the same days as teamLab Planets

[New coronavirus measures (applicable to the Food & Shop)]

  • Implementation of regular cleaning and disinfection
  • Seat disinfection after each customer
  • Hand disinfection upon entry
  • Restrictions on the number of people in the space
  • Ensuring sufficient space between seats
  • Employees wear masks
  • Removal of tabletop items
  • Temperature measurement

[Press kit]

https://goo.gl/tQXMLm

[PLANETS Co., Ltd.]

Established in 2017. Operates and manages the facilities of teamLab Planets TOKYO.
Location: Tokyo Nihonbashi Tower 10F, 2-7-1 Nihonbashi, Chuo-ku, Tokyo
Representative: Takumi Nomoto

[teamLab]

teamLab (f. 2001) is an international art collective. Their collaborative practice seeks to navigate the confluence of art, science, technology, and the natural world. Through art, the interdisciplinary group of specialists, including artists, programmers, engineers, CG animators, mathematicians, and architects, aims to explore the relationship between the self and the world, and new forms of perception.

In order to understand the world around them, people separate it into independent entities with perceived boundaries between them. teamLab seeks to transcend these boundaries in our perceptions of the world, of the relationship between the self and the world, and of the continuity of time. Everything exists in a long, fragile yet miraculous, borderless continuity.

teamLab exhibitions have been held in cities worldwide, including New York, London, Paris, Singapore, Silicon Valley, Beijing, and Melbourne among others. teamLab museums and large-scale permanent exhibitions include teamLab Borderless and teamLab Planets in Tokyo, teamLab Borderless Shanghai, and teamLab SuperNature Macao, with more to open in cities including Abu Dhabi, Beijing, Hamburg, Jeddah, and Utrecht.

teamLab’s works are in the permanent collection of the Museum of Contemporary Art, Los Angeles; Art Gallery of New South Wales, Sydney; Art Gallery of South Australia, Adelaide; Asian Art Museum, San Francisco; Asia Society Museum, New York; Borusan Contemporary Art Collection, Istanbul; National Gallery of Victoria, Melbourne; and Amos Rex, Helsinki.

teamLab: https://www.teamlab.art/
Instagram: https://instagram.com/teamlab/
Facebook: https://www.facebook.com/teamLab.inc
Twitter: https://twitter.com/teamLab_net
YouTube: https://www.youtube.com/c/teamLabART

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

[Inquiries regarding releases and interviews]
PLANETS Co., Ltd. Public Relations Department
E-mail: pr-info@planets.art
Interview: https://forms.gle/fAtnDKLpQKFME6XR9

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Incyte Announces Phase 1 Results for its TGFβR2×PD-1 Bispecific Antibody in Advanced Colorectal Cancer and KRAS G12D Inhibitor in Advanced Pancreatic Ductal Adenocarcinoma19.10.2025 20:30:00 EEST | Press release

Incyte (Nasdaq:INCY) announced the first clinical data evaluating its TGFβR2×PD-1 bispecific antibody (INCA33890) for patients with microsatellite stable (MSS) colorectal cancer; and its potent, selective and orally bioavailable KRAS G12D inhibitor (INCB161734) for patients with KRAS G12D mutations, specifically pancreatic ductal adenocarcinoma (PDAC). The data were featured in two oral sessions (Investigational immunotherapy; Abstract #1522MO and Developmental therapeutics; Abstract #916O, respectively) at the European Society of Medical Oncology (ESMO) Congress 2025. “The proof-of-concept data highlight the potential of INCA33890 and INCB161734 to address significant medical needs in patients with advanced solid tumors, including MSS colorectal cancer and PDAC,” said Pablo J. Cagnoni, M.D., President and Head of Research and Development, Incyte. “These results, including the favorable safety profiles as monotherapies, support continued clinical development. We look forward to explori

Corcept Presents ESMO 2025 Late-Breaker: Relacorilant Demonstrates Benefit in Patients with Platinum-Resistant Ovarian Cancer with Prior PARP Inhibitor Treatment19.10.2025 12:15:00 EEST | Press release

Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today shared new late-breaking data from its pivotal Phase 3 ROSELLA trial of relacorilant plus nab-paclitaxel in patients with platinum-resistant ovarian cancer at the European Society for Medical Oncology (ESMO) 2025 Annual Meeting. The data demonstrated a progression-free survival (PFS) benefit for patients who experienced disease progression while on or after taking a PARP inhibitor (PARPi), a patient population with particularly poor prognosis. The presentation slides can be found here. The company also announced expansion of the Phase 2 BELLA trial in a poster session at ESMO, found here. New relacorilant data presented at ESMO demonstrated a consistent benefit in PARPi subgroups to overcome chemotherapy resistance. Relaco

Deciphera Presents 2-Year Efficacy and Safety Results from MOTION Phase 3 Study of ROMVIMZA ™ (vimseltinib) in Patients with Tenosynovial Giant Cell Tumor (TGCT) at the European Society for Medical Oncology Congress 202518.10.2025 14:00:00 EEST | Press release

Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced the two-year efficacy and safety results from its MOTION Phase 3 study of vimseltinib in patients with TGCT in cases where surgical removal of the tumor is not an option will be presented as a poster during the 2025 European Society for Medical Oncology Congress (ESMO), taking place October 17-21 in Berlin, Germany. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251018921529/en/ “These long-term Phase 3 MOTION results add to the established body of evidence supporting vimseltinib as a best-in-class treatment for TGCT,” said Matthew L. Sherman, M.D., Chief Medical Officer of Deciphera. “TGCT often causes debilitating pain, stiffness and impaired mobility and these results demonstrate the durable benefit that vimseltinib can offer patients.” Summary of Data and Findings from the 2-year results of the MOTION Phase

ProAmpac Acquires International Paper’s Bag Converting Operations17.10.2025 17:09:00 EEST | Press release

ProAmpac, a global leader in flexible packaging and material science, has acquired the bag converting operations of International Paper (“IP”), a global leader in sustainable packaging. The acquisition expands ProAmpac’s converting capabilities, further advancing the company’s Fiberization of Packaging® strategy and enhancing its ability to deliver customized bag solutions for the grocery, convenience store, and quick-service restaurant markets. “Global demand for reliable, recyclable paper packaging continues to grow rapidly amid evolving consumer expectations and market trends redefining recyclability,” stated Greg Tucker, ProAmpac founder, vice chairman, and chief executive officer. “ProAmpac’s acquisition of IP’s bag operation supports our Fiberization of Packaging initiatives, helping us better serve customers by extending our expertise in material science to the US west coast with additional capabilities and redundancies,” continued Tucker. “IP’s bag business is strong, being bui

Pimicotinib Treatment Demonstrates Deep and Durable Tumor Responses and Continued Improvements in Pain and Function for Patients with TGCT17.10.2025 17:00:00 EEST | Press release

Merck, a leading science and technology company, today announced the presentation of longer-term results from the global Phase 3 MANEUVER trial evaluating pimicotinib, an investigational colony stimulating factor-1 receptor (CSF-1R) inhibitor in development by Abbisko Therapeutics Co., Ltd., for the treatment of patients with tenosynovial giant cell tumor (TGCT). This latest analysis showed that, with a median follow-up of 14.3 months, the objective response rate (ORR) for people treated with pimicotinib from the beginning of the study increased considerably to 76.2% (95% CI: 63.8, 86.0) by blinded independent review committee (BICR) per RECIST v1.1, from 54% at Week 25. The study also showed continued clinically meaningful improvements in key secondary endpoints related to patient outcomes such as pain and function. The safety profile was consistent with previously reported data. The results are being presented today in the Sarcoma mini-oral session at the European Society for Medical

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye